Butterfield, D. ., & Castegna, A. . (2003). Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids, 25(3-4), 419-25. https://doi.org/10.1007/s00726-003-0027-7

Drake, J. ., Sultana, R. ., Aksenova, M. ., , & Butterfield, D. . (2003). Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. Journal of Neuroscience Research, 74(6), 917-27. https://doi.org/10.1002/jnr.10810 (Original work published 2003)

Butterfield, D. . (2003). Amyloid beta-peptide 1-42 -associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences. Current Medicinal Chemistry, 10(24), 2651-9. https://doi.org/10.2174/0929867033456422

Butterfield, D. ., & Castegna, A. . (2003). Proteomic analysis of oxidatively modified proteins in Alzheimer’s disease brain: insights into neurodegeneration. Cellular and Molecular Biology (Noisy-Le-Grand, France), 49(5), 747-51.

Kanski, J. ., Sultana, R. ., Klunk, W. ., & Butterfield, D. . (2003). Antioxidant activity of X-34 in synaptosomal and neuronal systems. Brain Research, 988(1-2), 173-9. https://doi.org/10.1016/s0006-8993(03)03369-9 (Original work published 2003)

Downie, A. ., Zhang, D. ., Dirk, L. ., Thacker, R. ., Pfeiffer, J. ., Drake, J. ., … Snyder, J. . (2003). Communication between the maternal testa and the embryo and/or endosperm affect testa attributes in tomato. Plant Physiology, 133(1), 145-60. https://doi.org/10.1104/pp.103.022632

Butterfield, D. ., Boyd-Kimball, D. ., & Castegna, A. . (2003). Proteomics in Alzheimer’s disease: insights into potential mechanisms of neurodegeneration. Journal of Neurochemistry, 86(6), 1313-27. https://doi.org/10.1046/j.1471-4159.2003.01948.x

Ding, Q. ., Reinacker, K. ., Dimayuga, E. ., , Drake, J. ., Butterfield, D. ., … Keller, J. . (2003). Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Letters, 546(2-3), 228-32. https://doi.org/10.1016/s0014-5793(03)00582-9 (Original work published 2003)

Kanski, J. ., Aksenova, M. ., & Butterfield, D. . (2002). The hydrophobic environment of Met35 of Alzheimer’s Abeta(1-42) is important for the neurotoxic and oxidative properties of the peptide. Neurotoxicity Research, 4(3), 219-23. https://doi.org/10.1080/10298420290023945

Butterfield, D. ., & Pocernich, C. . The glutamatergic system and Alzheimer’s disease: therapeutic implications. CNS Drugs, 17(9), 641-52. https://doi.org/10.2165/00023210-200317090-00004 (Original work published 2003)